Role of Bortezomib in the Treatment of Multiple Myeloma: First Results from a Representative Multicentre Treatment Survey in Germany Jul 20, 2023
Metastatic esophagogastric adenocarcinoma: trends in first-line treatment and predictive factors for the implementation of HER2 testing in clinical practice during the first year after trastuzumab market approval Jul 20, 2023
Evolving Treatment Trends in Relapsed/Refractory Multiple Myeloma in Europe from 2016 to 2018: Analysis of a Multi-National Survey Jul 20, 2023
Diagnostic and therapeutic approaches to multiple myeloma patients: Real-world data from representative multicentre treatment surveys in Germany between 2008 and 2011 Jul 20, 2023
